When CP CML cells were sorted based on CD34 expression, the CD34-positive progenitor cells showed good sensitivity to TKIs, whereas the more mature CD34-negative cells were markedly less sensitive. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.